Chemed CHE Earnings per common share - diluted (in dollars per share)
Earnings per common share - diluted (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Chemed's earnings per common share - diluted (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Chemed's earnings per common share - diluted (in dollars per share)?
- Chemed (CHE) reported earnings per common share - diluted (in dollars per share) of $4.84 in Q1 2026.
- How has Chemed's earnings per common share - diluted (in dollars per share) changed year-over-year?
- Chemed's earnings per common share - diluted (in dollars per share) decreased by 0.4% year-over-year, from $4.86 to $4.84.
- What is the long-term trend for Chemed's earnings per common share - diluted (in dollars per share)?
- Over 4 years (2021 to 2025), Chemed's earnings per common share - diluted (in dollars per share) has grown at a 2.1% compound annual growth rate (CAGR), from $16.86 to $18.34.
- What does earnings per common share - diluted (in dollars per share) mean?
- This metric measures the earnings per share assuming all potentially dilutive securities, such as stock options or convertible debt, are exercised or converted into common stock. It provides a conservative view of profitability by showing the potential impact of share dilution on existing shareholders. Investors use this to assess the impact of equity-based compensation and financing structures.